UK First: Frozen Testicular Tissue Transplanted to Restore Fertility After Chemotherapy
Surgeons in Edinburgh transplanted previously frozen testicular tissue back into a 19-year-old student in August, the first procedure of its kind in the UK and only the second reported worldwide. The Guardian
The operation was carried out by NHS Lothian doctors and reported on 8 October 2026. The patient had tissue removed and frozen in 2023, three years earlier, before treatment for a serious blood disorder. He then had a bone marrow transplant and chemotherapy. The Mirror
Three years after chemotherapy, tests found no sperm in his semen. The team thawed the stored tissue and put it back into his body, a process called autotransplantation, to try to restart sperm production from the remaining pool of sperm-forming cells.
The tissue holds spermatogonial stem cells. These are self-renewing cells that make sperm from puberty onward, a bit like a seed stock that keeps supplying new cells. Chemotherapy can permanently destroy that stock, which leaves children treated before they can bank sperm at risk of infertility as adults. Freezing tissue before damaging treatment, known as gonadotoxic therapy, is therefore the only preservation option for boys before puberty and for teens who cannot provide a semen sample.
The Edinburgh operation followed ten years of research at the University of Edinburgh and was funded by Children with Cancer UK. Doctors said they expect to know within months if the graft can produce usable sperm. Function will be checked with repeated semen tests, not assumed from the surgery alone.
ITV News also reported the case on 7 October 2026 as a UK first in transplanting frozen testicular tissue to restore fertility. ITV News
The broader context here is a shift from storage to use. Freezing testicular tissue has been offered for more than ten years to high-risk patients who cannot store sperm, including young boys with cancer. University College London Hospitals lists ovarian and testicular tissue freezing as specialist surgery for these patients, and NHS England describes it as the only treatment to preserve fertility and hormone function in this group. Until recently, live births had followed ovarian tissue transplants, while no matching success had been reported with transplanted testicular tissue.
That changed in May 2026, when a transplant of testicular tissue frozen before puberty was reported to have restored sperm production in an adult for the first time. The Guardian The Edinburgh case is the next clinical test of that method. An earlier example dates to 2015, when nine-year-old Nathan Crawford had testicular tissue frozen in the UK before treatment for a brain tumour, which showed freezing before treatment was feasible in children.
Looking at what this means for fertility preservation, the open technical questions are graft survival, how long sperm production lasts, and sperm quality. Transplanting a patient's own tissue has a different risk pattern from injecting stem cells or maturing cells in the lab, especially the risk of putting cancer cells back in patients treated for blood disease. Data on hormone recovery, time until sperm appears in semen, and use in assisted reproduction will decide whether this moves from an experimental step to routine survivorship care. For now, the Edinburgh transplant is a completed operation with an unproven result. Confirmation depends on months of follow-up.
